Generalized Evolutionary Classifier for Evolutionary Guided Precision Medicine

This is the authors' abstract. We don't add key points for this paper.

The first two DPM moves provide most of the clinical benefit of DPM, reducing the duration required for subclone monitoring. This also leads to an evolutionary classifier selecting patients who will benefit: those in whom DPM and CPM recommendations differ early. These advances bring DPM (and potentially other EGPM approaches) closer to potential clinical testing.